Advertisement

Cellular and Molecular Neurobiology

, Volume 26, Issue 1, pp 45–52 | Cite as

14-3-3 Protein, Total Tau and Phosphorylated Tau in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease and Neurodegenerative Disease in Japan

  • Katsuya Satoh
  • Susumu Shirabe
  • Hiroto Eguchi
  • Akira Tsujino
  • Katsumi Eguchi
  • Akira Satoh
  • Mitsuhiro Tsujihata
  • Masami Niwa
  • Shigeru Katamine
  • Saiko Kurihara
  • Hidenori Matsuo
Article

Summary

  1. 1.

    Sporadic Creutzfeldt-Jakob disease (CJD) is a rapidly progressive and fatal disease. Patients with CJD usually become akinetic mutism within approximately 6 months. In addition, clinical signs and symptoms at early stage of sporadic CJD may not be easy to distinguish from other neurodegenerative diseases by neurological findings. However, diagnostic biochemical parameters including 14-3-3 protein, S100, neuron-specific enorase in cerebrospinal fluid (CSF) have been used as diagnostic markers, elevated titers of these markers can also be observed in CSF in other neurodegenerative diseases. Therefore, we examined other biochemical markers to discriminate CJD from other neurodegenerative diseases in CSF.

     
  2. 2.

    We analyzed CSF samples derived from 100 patients with various neurodegenerative disorders by Western blot of 14-3-3 protein, quantification of total tau (t-tau) protein, and phosphorylated tau (p-tau) protein. All patients with CJD in this study showed positive 14-3-3 protein and elevated t-tau protein (>1000 pg/mL) in CSF. We also detected positive 14-3-3 protein bands in two patients in non-CJD group (patients with dementia of Alzheimer's type; DAT) and also detected elevated t-tau protein in three patients in non-CJD group. Elevated t-tau protein levels were observed in two patients with DAT and in one patient with cerevrovascular disease in acute phase.

     
  3. 3.

    To distinguish patients with CJD from non-CJD patients with elevated t-tau protein in CSF, we compared the ratio of p-tau and t-tau proteins. The p-/t-tau ratio was dramatically and significantly higher in DAT patients rather than in CJD patients.

     
  4. 4.

    Therefore, we concluded that the assay of t-tau protein may be useful as 1st screening and the ratio of p-tau protein/t-tau protein would be useful as 2nd screening to discriminate CJD from other neurodegenerative diseases.

     

Keywords

tau phosphorylated tau 14-3-3 protein diagnosis cerebrospinal fluid dementia of Alzheimer type Creutzfeldt-Jakob disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Demerosl, P., and Heiner, L., et al. (1999). Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology 52(1):205–208.Google Scholar
  2. Hsich, G., and Kenney, K., et al. (1996). The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335(13):924–930.CrossRefPubMedGoogle Scholar
  3. Masters, C. L., Harris, J. O., Gajdusek, D. C., Gibbs, C. J., Jr., Bernoulli, C., and Asher, D. M.(1979). Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann. Neurol. 5(2):177–188.CrossRefPubMedGoogle Scholar
  4. Otto, M., and Wiltfang, J., et al. (2002). Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58(2):192–197.PubMedGoogle Scholar
  5. Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., Poser, S., Rojiani, A., Streichemberger, N., Julien, J., Vital, C., Ghetti, B., Gambetti, P., and Kretzschmar, H. (1999). Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46(2):224–233.CrossRefPubMedGoogle Scholar
  6. Van Everbroeck, B., Quoilin, S., Boons, J., Martin, J. J., and Cras, P. (2003). A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiatry 74(9):1210–1214.CrossRefPubMedGoogle Scholar
  7. Zerr, I., Bodemer, M., and Gefeller, O., et al. (1998). Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann. Neurol. 43(1):32–40.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • Katsuya Satoh
    • 1
  • Susumu Shirabe
    • 1
  • Hiroto Eguchi
    • 1
  • Akira Tsujino
    • 1
  • Katsumi Eguchi
    • 1
  • Akira Satoh
    • 2
  • Mitsuhiro Tsujihata
    • 2
  • Masami Niwa
    • 3
  • Shigeru Katamine
    • 4
  • Saiko Kurihara
    • 5
  • Hidenori Matsuo
    • 6
  1. 1.The First Department of Internal MedicineNagasaki University Graduate School of Biomedical ScienceNagasakiJapan
  2. 2.Nagasaki Kita HospitalNagasakiJapan
  3. 3.Department of ParmacologyNagasaki University Graduate School of Biomedical ScienceNagasakiJapan
  4. 4.Department of Molecular Microbiology and ImmunologyNagasaki University Graduate School of Biomedical ScienceNagasakiJapan
  5. 5.Matsue Red Cross HospitalShimaneJapan
  6. 6.Kawatana National HospitalNagasakiJapan

Personalised recommendations